| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.96e-05 | 507 | 39 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.96e-05 | 507 | 39 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | APC RANBP2 PPP6R1 ARHGAP11A TRIO MYCBP2 BIRC6 ARHGAP31 SLX4 ASAP1 ARHGAP12 | 5.84e-05 | 1418 | 39 | 11 | GO:0030234 |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.01e-04 | 279 | 39 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.83e-04 | 321 | 39 | 5 | GO:0031267 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.44e-04 | 360 | 39 | 5 | GO:0051020 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.59e-03 | 656 | 39 | 6 | GO:0008047 | |
| HumanPheno | Aplasia/Hypoplasia of the radius | 2.80e-05 | 82 | 12 | 4 | HP:0006501 | |
| HumanPheno | Aplasia/hypoplasia involving forearm bones | 6.13e-05 | 100 | 12 | 4 | HP:0006503 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 8.42e-05 | 366 | 12 | 6 | HP:0006265 | |
| HumanPheno | Toe syndactyly | 1.45e-04 | 244 | 12 | 5 | HP:0001770 | |
| HumanPheno | Hydrocephalus | 1.85e-04 | 421 | 12 | 6 | HP:0000238 | |
| HumanPheno | Alternating esotropia | 2.27e-04 | 10 | 12 | 2 | HP:0001137 | |
| HumanPheno | Abnormal cerebrospinal fluid morphology | 2.27e-04 | 646 | 12 | 7 | HP:0002921 | |
| HumanPheno | Hypoplasia of the ulna | 2.45e-04 | 55 | 12 | 3 | HP:0003022 | |
| HumanPheno | Aplasia/Hypoplasia of the ulna | 3.17e-04 | 60 | 12 | 3 | HP:0006495 | |
| HumanPheno | Abnormality of globe location or size | 3.22e-04 | 1246 | 12 | 9 | HP:0000489 | |
| HumanPheno | Recurrent urinary tract infections | 3.54e-04 | 157 | 12 | 4 | HP:0000010 | |
| HumanPheno | Urinary tract infections | 3.72e-04 | 159 | 12 | 4 | HP:0000094 | |
| HumanPheno | Urinary bladder inflammation | 3.72e-04 | 159 | 12 | 4 | HP:0100577 | |
| HumanPheno | Crossed fused renal ectopia | 4.56e-04 | 14 | 12 | 2 | HP:0004736 | |
| Domain | - | 1.47e-04 | 391 | 39 | 6 | 2.30.29.30 | |
| Domain | PH_dom-like | 2.34e-04 | 426 | 39 | 6 | IPR011993 | |
| Domain | PH | 2.68e-04 | 278 | 39 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 2.73e-04 | 279 | 39 | 5 | PS50003 | |
| Domain | - | 2.77e-04 | 12 | 39 | 2 | 3.90.810.10 | |
| Domain | PH_domain | 2.77e-04 | 280 | 39 | 5 | IPR001849 | |
| Domain | RhoGAP | 2.92e-04 | 62 | 39 | 3 | SM00324 | |
| Domain | RhoGAP | 3.07e-04 | 63 | 39 | 3 | PF00620 | |
| Domain | RHOGAP | 3.21e-04 | 64 | 39 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 3.21e-04 | 64 | 39 | 3 | IPR000198 | |
| Domain | - | 3.21e-04 | 64 | 39 | 3 | 1.10.555.10 | |
| Domain | PBD | 5.01e-04 | 16 | 39 | 2 | SM00285 | |
| Domain | PBD | 5.66e-04 | 17 | 39 | 2 | PF00786 | |
| Domain | CRIB | 7.88e-04 | 20 | 39 | 2 | PS50108 | |
| Domain | Rho_GTPase_activation_prot | 8.17e-04 | 88 | 39 | 3 | IPR008936 | |
| Domain | CRIB_dom | 8.70e-04 | 21 | 39 | 2 | IPR000095 | |
| Domain | PH | 1.29e-03 | 229 | 39 | 4 | PF00169 | |
| Domain | C2 | 3.22e-03 | 142 | 39 | 3 | PS50004 | |
| Domain | - | 3.62e-03 | 148 | 39 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 4.82e-03 | 164 | 39 | 3 | IPR000008 | |
| Domain | SH3_1 | 4.82e-03 | 164 | 39 | 3 | PF00018 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.72e-04 | 55 | 28 | 3 | M41815 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.85e-04 | 439 | 28 | 6 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.12e-04 | 450 | 28 | 6 | M27078 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.15e-04 | 649 | 28 | 7 | MM15690 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.34e-04 | 155 | 28 | 4 | M41808 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 3.72e-04 | 175 | 28 | 4 | MM15599 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION | 3.93e-04 | 15 | 28 | 2 | M47854 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 4.06e-04 | 720 | 28 | 7 | M41838 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.50e-04 | 184 | 28 | 4 | M41809 | |
| Pubmed | APC PAK3 RANBP2 LRRC7 PPP6R1 WASHC2C TRIO MYCBP2 BIRC6 CDC42BPB PCM1 ASAP1 | 3.44e-09 | 1139 | 40 | 12 | 36417873 | |
| Pubmed | 3.51e-09 | 486 | 40 | 9 | 20936779 | ||
| Pubmed | APC PAK3 RANBP2 LRRC7 PPP6R1 SPATS2 FAM120A TRIO MYCBP2 CDC42BPB PCM1 | 7.69e-09 | 963 | 40 | 11 | 28671696 | |
| Pubmed | 2.24e-08 | 418 | 40 | 8 | 34709266 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.98e-08 | 475 | 40 | 8 | 31040226 | |
| Pubmed | 8.46e-08 | 497 | 40 | 8 | 23414517 | ||
| Pubmed | 1.42e-07 | 209 | 40 | 6 | 36779422 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.26e-07 | 853 | 40 | 9 | 28718761 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22962686 | ||
| Pubmed | 1.37e-06 | 493 | 40 | 7 | 15368895 | ||
| Pubmed | Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. | 3.87e-06 | 3 | 40 | 2 | 20212110 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21807912 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 26201900 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 26146642 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 5.21e-06 | 861 | 40 | 8 | 36931259 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 PAK3 LRRC7 SPATS2 FAM120A TRIO MYCBP2 CDC42BPB MAML3 PCM1 | 5.25e-06 | 1489 | 40 | 10 | 28611215 |
| Pubmed | 7.11e-06 | 107 | 40 | 4 | 11347906 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 20299682 | ||
| Pubmed | Nup358 interacts with APC and plays a role in cell polarization. | 7.73e-06 | 4 | 40 | 2 | 19654215 | |
| Pubmed | MicroRNA-146a limits tumorigenic inflammation in colorectal cancer. | 7.73e-06 | 4 | 40 | 2 | 33893298 | |
| Pubmed | Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis. | 1.29e-05 | 5 | 40 | 2 | 26880802 | |
| Pubmed | CCM-3/STRIPAK promotes seamless tube extension through endocytic recycling. | 1.29e-05 | 5 | 40 | 2 | 25743393 | |
| Pubmed | 1.68e-05 | 133 | 40 | 4 | 15144186 | ||
| Pubmed | 1.83e-05 | 733 | 40 | 7 | 34672954 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 17450144 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 24412611 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 18786926 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 30650375 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 20493731 | ||
| Pubmed | 2.84e-05 | 1431 | 40 | 9 | 37142655 | ||
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 2.91e-05 | 313 | 40 | 5 | 16196087 | |
| Pubmed | Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. | 3.60e-05 | 8 | 40 | 2 | 23241743 | |
| Pubmed | In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. | 4.62e-05 | 9 | 40 | 2 | 18504307 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.36e-05 | 588 | 40 | 6 | 38580884 | |
| Pubmed | Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. | 7.05e-05 | 11 | 40 | 2 | 23034650 | |
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 33113356 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 29398651 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 24362892 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.06e-05 | 398 | 40 | 5 | 35016035 | |
| Pubmed | 9.11e-05 | 1285 | 40 | 8 | 35914814 | ||
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 18586681 | ||
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 36630911 | ||
| Pubmed | 1.23e-04 | 222 | 40 | 4 | 37071664 | ||
| Pubmed | 1.30e-04 | 430 | 40 | 5 | 32581705 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 1.32e-04 | 226 | 40 | 4 | 25900982 | |
| Pubmed | 1.34e-04 | 1006 | 40 | 7 | 15226823 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.46e-04 | 232 | 40 | 4 | 25515538 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 29045831 | ||
| Pubmed | Lung Epithelial Cells Coordinate Innate Lymphocytes and Immunity against Pulmonary Fungal Infection. | 1.53e-04 | 16 | 40 | 2 | 29576482 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 27760317 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.67e-04 | 724 | 40 | 6 | 36232890 | |
| Pubmed | 1.74e-04 | 1049 | 40 | 7 | 27880917 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.83e-04 | 736 | 40 | 6 | 29676528 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.13e-04 | 256 | 40 | 4 | 33397691 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 2.24e-04 | 102 | 40 | 3 | 15778465 | |
| Pubmed | 2.30e-04 | 103 | 40 | 3 | 10574462 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.40e-04 | 774 | 40 | 6 | 15302935 | |
| Pubmed | 2.69e-04 | 503 | 40 | 5 | 16964243 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 20301575 | ||
| Pubmed | 3.80e-04 | 25 | 40 | 2 | 12522145 | ||
| Pubmed | 4.78e-04 | 28 | 40 | 2 | 38324473 | ||
| Pubmed | 6.26e-04 | 1297 | 40 | 7 | 33545068 | ||
| Pubmed | 6.70e-04 | 347 | 40 | 4 | 17114649 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.00e-04 | 351 | 40 | 4 | 38297188 | |
| Pubmed | Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. | 7.07e-04 | 34 | 40 | 2 | 23533177 | |
| Pubmed | Systematic and quantitative assessment of the ubiquitin-modified proteome. | 8.03e-04 | 158 | 40 | 3 | 21906983 | |
| Pubmed | 8.64e-04 | 162 | 40 | 3 | 21890473 | ||
| Pubmed | 8.78e-04 | 653 | 40 | 5 | 22586326 | ||
| Pubmed | 8.90e-04 | 655 | 40 | 5 | 35819319 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 9.12e-04 | 377 | 40 | 4 | 38117590 | |
| Interaction | PHF21A interactions | 3.75e-06 | 343 | 39 | 7 | int:PHF21A | |
| Interaction | GOLGA1 interactions | 2.62e-05 | 183 | 39 | 5 | int:GOLGA1 | |
| Interaction | GSK3A interactions | 2.66e-05 | 464 | 39 | 7 | int:GSK3A | |
| Interaction | FXR1 interactions | 3.89e-05 | 679 | 39 | 8 | int:FXR1 | |
| Interaction | RCOR1 interactions | 3.97e-05 | 494 | 39 | 7 | int:RCOR1 | |
| Interaction | PCNA interactions | 4.13e-05 | 497 | 39 | 7 | int:PCNA | |
| Interaction | PLK1 interactions | 4.86e-05 | 510 | 39 | 7 | int:PLK1 | |
| Interaction | CDKL5 interactions | 6.62e-05 | 113 | 39 | 4 | int:CDKL5 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 8.47e-05 | 50 | 31 | 3 | 721 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.30e-04 | 20 | 31 | 2 | 548 | |
| Coexpression | GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP | 1.15e-05 | 200 | 39 | 5 | M9699 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.43e-07 | 564 | 39 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 182 | 40 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 185 | 40 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 1.15e-05 | 156 | 40 | 4 | 01f2c0c6a936dfb59bc727feef428a906ad2a80b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 184 | 40 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.66e-05 | 193 | 40 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.77e-05 | 195 | 40 | 4 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 198 | 40 | 4 | 2bba5a2f584b00d35d008d9c2d8fb3e712fc3a73 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.05e-05 | 200 | 40 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.15e-05 | 174 | 39 | 5 | 7530_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A | 1.94e-05 | 194 | 39 | 5 | 1947_DN | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 7294_UP | |
| Disease | Leukemia, Myelocytic, Acute | 8.00e-05 | 173 | 39 | 4 | C0023467 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.01e-04 | 355 | 39 | 5 | EFO_0004784, EFO_0008354 | |
| Disease | Bone marrow hypocellularity | 2.57e-04 | 18 | 39 | 2 | C1855710 | |
| Disease | Adenocarcinoma of large intestine | 2.80e-04 | 96 | 39 | 3 | C1319315 | |
| Disease | Pancreatic carcinoma | 2.87e-04 | 19 | 39 | 2 | C0235974 | |
| Disease | Fanconi Anemia | 5.01e-04 | 25 | 39 | 2 | C0015625 | |
| Disease | Acute monocytic leukemia | 5.42e-04 | 26 | 39 | 2 | C0023465 | |
| Disease | Pancytopenia | 5.42e-04 | 26 | 39 | 2 | C0030312 | |
| Disease | stimulant use measurement | 6.30e-04 | 28 | 39 | 2 | EFO_0600076 | |
| Disease | Miller Dieker syndrome | 6.76e-04 | 29 | 39 | 2 | C0265219 | |
| Disease | verbal-numerical reasoning measurement | 6.95e-04 | 131 | 39 | 3 | EFO_0008394 | |
| Disease | Bladder Neoplasm | 8.43e-04 | 140 | 39 | 3 | C0005695 | |
| Disease | neuroticism measurement, cognitive function measurement | 8.57e-04 | 566 | 39 | 5 | EFO_0007660, EFO_0008354 | |
| Disease | Malignant neoplasm of urinary bladder | 8.61e-04 | 141 | 39 | 3 | C0005684 | |
| Disease | Abnormality of radial ray | 8.76e-04 | 33 | 39 | 2 | C4228778 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.33e-03 | 364 | 39 | 4 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | health study participation | 2.18e-03 | 195 | 39 | 3 | EFO_0010130 | |
| Disease | cognitive function measurement | 2.47e-03 | 1434 | 39 | 7 | EFO_0008354 | |
| Disease | eye morphology measurement | 2.99e-03 | 218 | 39 | 3 | EFO_0007858 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.56e-03 | 67 | 39 | 2 | C3463824 | |
| Disease | body fat percentage | 3.85e-03 | 488 | 39 | 4 | EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NNLHTQSLNRSSKGS | 2206 | Q9NR09 | |
| NHNAATKRQSSLSAS | 1321 | Q9BXF3 | |
| QELKLNSSNSASPHR | 826 | P49792 | |
| SRSHQNSPTELNKDR | 946 | Q08999 | |
| AFHAALRNSPVNTKN | 56 | Q9BPX5 | |
| NNRDSSALNHSSKPL | 21 | O75914 | |
| NTKPLTHFNADLSQR | 601 | Q96JK9 | |
| AENANSNPLLSSKSR | 786 | Q96NW7 | |
| LLNSASQHSPDSLKN | 431 | O15327 | |
| LDQKNRASPQHSASG | 1606 | Q2KJY2 | |
| SNQALIPRDHSKNFT | 1276 | Q8IYD8 | |
| RDQHLNNSSASPQRS | 421 | Q15154 | |
| KTCNTNPHLNALSTD | 1086 | Q9NZB2 | |
| LHGSSRALSNSNRDK | 471 | Q9Y5S2 | |
| IHNRNTNTNPKRSSD | 51 | Q16552 | |
| QKNHLAPTNSDSTLQ | 1231 | Q96JM4 | |
| NDSHSPKVSSQNRTR | 161 | Q8IWW6 | |
| ANSQLSTSQPSLRHK | 51 | Q96C57 | |
| ISHATSNRQPAKLNL | 356 | Q9ULH1 | |
| PLSESLNHSSQIRNK | 566 | Q9Y267 | |
| SPASSDKNSNSNHRR | 1501 | Q13029 | |
| LFHNPSSKQSRNLAE | 66 | Q8N807 | |
| ATSCELTPSNLNNKH | 561 | Q6P4F7 | |
| LNNKHNSNITSSPLS | 571 | Q6P4F7 | |
| SAQNSSPSLSQHAKD | 101 | Q17RD7 | |
| FNLNTNSLHSAVPKR | 36 | A0A1B0GU33 | |
| RSLSPNHNTLQTLKS | 2786 | O75592 | |
| LTQSNPDHSSSRSQK | 1126 | Q8IY92 | |
| KRQNQLHPSSAQSRS | 1226 | P25054 | |
| SRNKENHSQPTQSSL | 86 | Q9BXN2 | |
| QKFPTDNISSSNRSH | 406 | Q70EK8 | |
| IHNSQQPRNAAKSLS | 196 | Q86XZ4 | |
| NSFSLSPLHSNTKIN | 296 | Q9UBZ9 | |
| ALASLSPHSNQQLDS | 1116 | A6NE52 | |
| HAQKSLDVSPRNLSQ | 196 | A6NKC9 | |
| LPAQADTLHSANKSR | 996 | Q9Y4E1 | |
| PRHSDKQNSKNAASE | 841 | Q2M1Z3 | |
| LFNKNPRHSSSENNS | 891 | Q4KWH8 | |
| PSKDENQHSNASQSL | 201 | Q9UPN7 | |
| IQHTNSLSRPNSFDK | 1136 | P15822 | |
| SRHPSLISSDSNNLK | 271 | Q86YD3 | |
| QQLRDSAISSNKTPH | 736 | O75962 |